Sign In to Follow Application
View All Documents & Correspondence

A Composition Comprising Bacopa Monnieri Extract, And Linolenic Acid

Abstract: The present disclosure relates to a composition comprising Bacopa monnieri extract, and linolenic acid , and uses thereof. The disclosure also provides for a method of use of the said composition for inhibiting production of reactive oxygen species.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
29 March 2016
Publication Number
40/2017
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
lsmds@lakshmisri.com
Parent Application
Patent Number
Legal Status
Grant Date
2021-09-17
Renewal Date

Applicants

ITC LIMITED
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058.

Inventors

1. SHETTY, Shilpa
ITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058.
2. KS, Nandakumar
ITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058.
3. RADHAKRISHNAN, Yashwanth
ITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058.
4. CHANDRASEKHARAN, Lakshmanan Chittur
ITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058.

Specification

Claims:1. A composition for comprising:
a) Bacopa monnieri extract ; and
b) linolenic acid,
wherein Bacopa monnieri extract to linolenic acid w/w ratio in said composition is in the range of 3:1-5:1.
2. The composition as claimed in claim 1, wherein Bacopa monnieri extract weight percent in said composition is in the range of 0.000225%-0.000275%, and linolenic acid weight percent in said composition is in the range of 0.000055-0.000075%.
3. The composition as claimed in claim 1, wherein Bacopa monnieri extract to linolenic acid w/w ratio in said composition is 4:1.
4. The composition as claimed in claim 3, wherein Bacopa monnieri extract weight percent in said composition is 0.00025%, and linolenic acid weight percent in said composition is 0.0000625%
5. The composition as claimed in any of the claims 1-4, further comprising at least one carrier, diluent, and excipient.
6. A method of preparing a composition as claimed in any of the claims 1-5.
7. A method for inhibiting production of reactive oxygen species, said method comprising the steps:
a. obtaining a composition as claimed in any of the claims 1-5; and
b. contacting said composition with a site of reactive oxygen production,
wherein said method inhibits production of reactive oxygen species.

8. A composition as claimed in any of the claims 1-5, for use in preparation of formulations for inhibiting production of reactive oxygen species.
, Description:As Attached

Documents

Orders

Section Controller Decision Date

Application Documents

# Name Date
1 201641010709-RELEVANT DOCUMENTS [29-09-2023(online)].pdf 2023-09-29
1 Form 5 [29-03-2016(online)].pdf 2016-03-29
2 201641010709-FER.pdf 2021-10-17
2 Form 3 [29-03-2016(online)].pdf 2016-03-29
3 Drawing [29-03-2016(online)].pdf 2016-03-29
3 201641010709-US(14)-HearingNotice-(HearingDate-04-08-2021).pdf 2021-10-17
4 Description(Complete) [29-03-2016(online)].pdf 2016-03-29
4 201641010709-IntimationOfGrant17-09-2021.pdf 2021-09-17
5 201641010709-PatentCertificate17-09-2021.pdf 2021-09-17
5 201641010709-Correspondence-030516.pdf 2016-07-15
6 201641010709-Written submissions and relevant documents [18-08-2021(online)].pdf 2021-08-18
6 201641010709-FORM-26 [20-12-2017(online)].pdf 2017-12-20
7 Correspondence By Agent_Form26_22-12-2017.pdf 2017-12-22
7 201641010709-Correspondence to notify the Controller [03-08-2021(online)].pdf 2021-08-03
8 201641010709-FORM 18 [27-03-2020(online)].pdf 2020-03-27
8 201641010709-FER_SER_REPLY [08-06-2021(online)].pdf 2021-06-08
9 201641010709-FORM 4(ii) [09-03-2021(online)].pdf 2021-03-09
9 201641010709-OTHERS [08-06-2021(online)].pdf 2021-06-08
10 201641010709-FORM 4(ii) [09-03-2021(online)].pdf 2021-03-09
10 201641010709-OTHERS [08-06-2021(online)].pdf 2021-06-08
11 201641010709-FER_SER_REPLY [08-06-2021(online)].pdf 2021-06-08
11 201641010709-FORM 18 [27-03-2020(online)].pdf 2020-03-27
12 201641010709-Correspondence to notify the Controller [03-08-2021(online)].pdf 2021-08-03
12 Correspondence By Agent_Form26_22-12-2017.pdf 2017-12-22
13 201641010709-FORM-26 [20-12-2017(online)].pdf 2017-12-20
13 201641010709-Written submissions and relevant documents [18-08-2021(online)].pdf 2021-08-18
14 201641010709-Correspondence-030516.pdf 2016-07-15
14 201641010709-PatentCertificate17-09-2021.pdf 2021-09-17
15 201641010709-IntimationOfGrant17-09-2021.pdf 2021-09-17
15 Description(Complete) [29-03-2016(online)].pdf 2016-03-29
16 201641010709-US(14)-HearingNotice-(HearingDate-04-08-2021).pdf 2021-10-17
16 Drawing [29-03-2016(online)].pdf 2016-03-29
17 201641010709-FER.pdf 2021-10-17
17 Form 3 [29-03-2016(online)].pdf 2016-03-29
18 Form 5 [29-03-2016(online)].pdf 2016-03-29
18 201641010709-RELEVANT DOCUMENTS [29-09-2023(online)].pdf 2023-09-29

Search Strategy

1 2020-09-0212-28-03E_02-09-2020.pdf

ERegister / Renewals

3rd: 16 Dec 2021

From 29/03/2018 - To 29/03/2019

4th: 16 Dec 2021

From 29/03/2019 - To 29/03/2020

5th: 16 Dec 2021

From 29/03/2020 - To 29/03/2021

6th: 16 Dec 2021

From 29/03/2021 - To 29/03/2022

7th: 16 Dec 2021

From 29/03/2022 - To 29/03/2023

8th: 07 Mar 2023

From 29/03/2023 - To 29/03/2024

9th: 10 Feb 2024

From 29/03/2024 - To 29/03/2025

10th: 10 Mar 2025

From 29/03/2025 - To 29/03/2026